// App-Quantinova.ai

2253 : Cardiovascular Disease, Other Purported Risk Factors, and Allopurinol-Associated Severe Cutaneous Adverse Reactions: A General Population-Based Cohort Study

Researchers

Presenter

  • Chio Yokose

Principal Investigators

  • Hui Xie

  • Gloria Li

  • Sharan K. Rai

  • Seoyoung C. Kim

  • Hyon K. Choi

Medical Centers

  • Arthritis Research Centre of Canada, Richmond, BC, Canada

  • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA

  • Health Sciences, Simon Fraser University, Vancouver, BC, Canada

  • Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA

  • Graduate School of Arts and Sciences, Harvard University, Cambridge, MA

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A